1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies
    Journal Article

    Lee, C. Y.; Shah, M. K.; Hoyos, D.; Solovyov, A.; Douglas, M.; Taur, Y.; Maslak, P.; Babady, N. E.; Greenbaum, B.; Kamboj, M.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos) – Associated distinct purpuric subtype of toxic erythema of chemotherapy: A retrospective review of 54 patients
    Research Letter

    Stoll, J. R.; Battle, L.; Moy, A.; Dusza, S. W.; Park, J. H.; Tallman, M. S.; Taylor, J.; Markova, A.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • A nutritional management algorithm in older patients with locally advanced esophageal cancer
    Journal Article

    Moy, R. H.; Sabwa, S.; Maron, S. B.; Shcherba, M.; Apollo, A.; Janjigian, Y. Y.; Ku, G. Y.; Tew, W. P.; Wu, A. J.; Jones, D. R.; more...
    Journal of Geriatric Oncology (2022)

    Fulltext@MSK | Save
  • Percutaneous cryoablation provides disease control for extra-abdominal desmoid-type fibromatosis comparable with surgical resection
    Journal Article

    Mandel, J. E.; Kim, D.; Yarmohammadi, H.; Ziv, E.; Keohan, M. L.; D’Angelo, S. P.; Gounder, M. M.; Whiting, K.; Qin, L. X.; Singer, S.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
    Research Letter

    King, A. C.; Weis, T. M.; Derkach, A.; Ball, S.; Pandey, M.; Mauro, M. J.; Goldberg, A. D.; Stahl, M.; Famulare, C.; Tallman, M. S.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation
    Journal Article

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
    Advances in Cell and Gene Therapy (2021)

    Fulltext@MSK | Save
  • Novel standards and emerging therapies for systemically treatment-naïve clear cell renal cell carcinoma - A rapidly changing landscape
    Review

    Kotecha, R. R.; Voss, M. H.
    Journal of Cancer Metastasis and Treatment (2021)

    Fulltext@MSK | Save
  • Considerations for use of hematopoietic growth factors in patients with cancer related to the COVID-19 pandemic
    Review

    Griffiths, E. A.; Alwan, L. M.; Bachiashvili, K.; Brown, A.; Cool, R.; Curtin, P.; Geyer, M. B.; Gojo, I.; Kallam, A.; Kidwai, W. Z.; more...
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Highly selective irreversible ITK inhibitor Cpi-818 reduces acute graft-versus host disease
    Meeting Abstract

    Lindner, S.; Lee, N.; Armijo, G. K.; Burgos da Silva, Marina; Herrera, P. S.; Nguyen, C. L.; Dwomoh, E. A.; Ghale, R.; Smith, M.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • BRUIN CLL-322: A phase 3 open-label, randomized study of fixed duration pirtobrutinib plus venetoclax and rituximab versus venetoclax and rituximab in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (trial in progress)
    Meeting Abstract

    Mato, A. R.; Wierda, W. G.; Pagel, J. M.; Davids, M. S.; Zinzani, P. L.; Lu, Y.; Liu, H.; Shahda, S.; Leow, C. C.; Tam, C. S.; more...
    Blood (2021)

    Fulltext@MSK | Save